Varenicline and the evaluation of neuropsychiatric adverse events in smokers

Biol Psychiatry. 2011 Jun 1;69(11):1017-8. doi: 10.1016/j.biopsych.2011.04.012.
No abstract available

Publication types

  • Comment
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzazepines / adverse effects*
  • Humans
  • Nicotinic Agonists / adverse effects*
  • Quinoxalines / adverse effects*
  • Smoking Cessation*
  • Tobacco Use Disorder / drug therapy*
  • Treatment Outcome
  • Varenicline

Substances

  • Benzazepines
  • Nicotinic Agonists
  • Quinoxalines
  • Varenicline